| 1 |
35579950 | Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment. | 2022 Jun 22 |
5 |
| 2 |
31247375 | Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies. | 2019 Oct 1 |
2 |
| 3 |
29749441 | Apoptosis of CD19+ chimeric antigen receptor T cells after treatment with chemotherapeutic agents. | 2018 Jul |
1 |
| 4 |
26823489 | Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment. | 2016 Mar |
6 |
| 5 |
27605551 | Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells. | 2016 Sep 7 |
1 |
| 6 |
23160467 | The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies. | 2013 Jan 10 |
7 |
| 7 |
21487929 | The role of constitutive androstane receptor in oxazaphosphorine-mediated induction of drug-metabolizing enzymes in human hepatocytes. | 2011 Aug |
10 |